Precigen

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.65-$2.17
Market Cap
$513.6M
Shares Short
28M

Financials

See more
Revenue (12 Mos)
$4.2M
Revenue Growth (YoY)
25.9%
Gross Profit (12 Mos)
-$53.1M
Diluted EPS
-$0.55

News

See more

Yahoo Finance • 2 years ago

Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse™ Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis

Yahoo Finance • 2 years ago

13 High Growth Pharma Stocks that are Profitable

Yahoo Finance • 3 years ago

Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference

Yahoo Finance • 3 years ago

Precigen to Host a Virtual R&D Event on January 24th to Share Safety and Efficacy Data from the Phase 1 Dose Escalation and Expansion Cohorts of PRGN-2012 AdenoVerse™ Immunotherapy in Recurrent Respiratory Papillomatosis

About

CEO
Dr. Helen Sabzevari MPH, Ph.D.
Address
20374 Seneca Meadows Parkway, Germantown, MD, United States, 20876
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
143